title: Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH.
authors.affiliation: Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
authors.forename: C
authors.initials: C
authors.lastname: Male
authors.forename: P
authors.initials: P
authors.lastname: Monagle
authors.forename: A K C
authors.initials: AK
authors.lastname: Chan
authors.forename: G
authors.initials: G
authors.lastname: Young
mesh_terms: D000367:Age Factors; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects*; D002648:Child; D002675:Child, Preschool; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D012307:Risk Factors; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D015507:Drugs, Investigational